GREY:ALEAF - Post by User
Post by
Isodog2018on Aug 16, 2019 4:01pm
194 Views
Post# 30037977
Aleafia: Q2 Recap: Medical Patient Growth is Blossoming
Aleafia: Q2 Recap: Medical Patient Growth is Blossoming Growing medical patient count. Aleafia Health has grown its patient count by 27% to 8,861 patients on August 13, 2019, from 6,959 patients, which is the highest patient count recorded. With a network of cannabis clinics, Aleafia has seen about 65,000 patients to date and is focused on significant investments in cannabis research. The Company is currently working on a study with Cronos Group (TSX:CRON) to look at the effects of cannabis on sleep. On January 25, 2019, Aleafia announced results of a peer-reviewed journal titled, Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis, featuring a cohort of 146 patients from its Cannabo medical clinic. The study found that 45% of patients regularly consuming benzodiazepines had stopped taking the medication within approximately six months of beginning medical cannabis. In our view, with a strong commitment to medical research, Aleafia Health is well poised to onboard some of the 70,000 CannTrust (TSX:TRST) patients that will be looking for a new LP. https://smallcappower.com/analyst-articles/aleafia-health-q2-financial-results/
https://stockhouse.com/news/newswire/2019/08/16/how-aleafia-health-delivered-record-earnings-and-beat-analyst-estimates
Have a great weekend
Cheers!